Evaxion Biotech A/S (EVAX) Stock Forecast & Price Target

$2.95

-0.11 (-3.59%)

(As of 10/4/2024 ET)

Evaxion Biotech A/S - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 2 Analyst Ratings

Sell
0

Hold
0

Buy
2

Based on 2 Wall Street analysts who have issued ratings for Evaxion Biotech A/S in the last 12 months, the stock has a consensus rating of "Buy." Out of the 2 analysts, 2 have given a buy rating for EVAX.

Consensus Price Target

$11.00
272.88% Upside

According to the 2 analysts' twelve-month price targets for Evaxion Biotech A/S, the average price target is $11.00. The highest price target for EVAX is $14.00, while the lowest price target for EVAX is $8.00. The average price target represents a forecasted upside of 272.88% from the current price of $2.95.

Get the Latest News and Ratings for EVAX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Evaxion Biotech A/S and its competitors.

EVAX Analyst Ratings Over Time

Type	Current Forecast 10/7/23 to 10/6/24	1 Month Ago 9/7/23 to 9/6/24	3 Months Ago 7/9/23 to 7/8/24	1 Year Ago 10/7/22 to 10/7/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	2 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$11.00	$11.00	$11.00	$90.00
Forecasted Upside	272.88% Upside	217.92% Upside	231.33% Upside	943.48% Upside
Consensus Rating	Buy	Buy	Buy	Buy

Retire off just one stock ticker? (Ad)

ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT make you rich. However, there is one stock that stands head and shoulders above everything else. It's currently trading for only $15...

Click here for the ticker >>>

EVAX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

EVAX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Evaxion Biotech A/S Stock vs. The Competition

Type	Evaxion Biotech A/S	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.79	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	272.88% Upside	10,592.03% Upside	7.03% Upside
News Sentiment Rating	Neutral News See Recent EVAX News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
9/26/2024	HC Wainwright 2 of 5 stars	Reiterated Rating	Buy ➝ Buy	$14.00 ➝ $14.00	+354.54%
4/2/2024	LADENBURG THALM/SH SH 4 of 5 stars	Upgrade	Neutral ➝ Buy	$8.00	+143.16%
3/31/2023	Lake Street Capital 3 of 5 stars	Lower Target	Buy	$180.00 ➝ $70.00	+536.36%
11/17/2022	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform	$160.00 ➝ $110.00	+397.74%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 02:46 AM ET.

EVAX Forecast - Frequently Asked Questions

: According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Evaxion Biotech A/S is $11.00, with a high forecast of $14.00 and a low forecast of $8.00.
: 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Evaxion Biotech A/S in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" EVAX shares.
: According to analysts, Evaxion Biotech A/S's stock has a predicted upside of 272.88% based on their 12-month stock forecasts.
: Evaxion Biotech A/S has been rated by research analysts at HC Wainwright in the past 90 days.
: Analysts like Evaxion Biotech A/S more than other "medical" companies. The consensus rating for Evaxion Biotech A/S is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how EVAX compares to other companies.